Blood Grouping Reagent Market by Product (Consumables, Instruments), by Technique (PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Other Techniques), by Test Type (Antibody Screening, HLA Typing, Cross-Matching Tests, ABO Blood Tests, Antigen Typing), by End-user (Hospitals, Blood Banks, Clinical Laboratories) and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

M2M Satellite Communication Market size was valued at USD 2,541 billion in 2021, growing at a CAGR of 7.73% from 2022-28. Blood grouping reagents Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product, technique, test type, end user and region. This report market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in Blood grouping reagents. Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks for the determination and identification of antibody type in patient’s and donors blood, in order to ensure the effective and safe transfusion of blood and to reduce the risks causing infections.  Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.

Global Blood Grouping Reagents Market Summary

Study Period

2023-29

Base Year

2022

CAGR

7.73%

Largest Market

Europe

Fastest Growing Market

North America
Blood Grouping Reagent Market Dynamics

Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lacking in the awareness, lack of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Blood Grouping Reagents Market Segmentation

Product
  • Consumables
  • Instruments
Technique
  • PCR-based and Microarray Technique
  • Assay-Based Techniques
  • Massively Parallel Sequencing Techniques
  • Other Techniques
Test Type
  • Antibody Screening
  • HLA Typing
  • Cross-Matching Tests
  • ABO Blood Tests
  • Antigen Typing
End-user
  • Hospitals
  • Blood Banks
  • Clinical Laboratories

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive Summary
  2. Global Blood Grouping Reagents Market Introduction
2.1. Global Blood Grouping Reagents  Market – Taxonomy 2.2. Global Blood Grouping Reagents  Market –Definitions 2.2.1. Product 2.2.2. Technique 2.2.3. Test Type 2.2.4. End-User
  1. Global Blood Grouping Reagents Market Dynamics
3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Blood Grouping Reagents  Market Dynamic Factors - Impact Analysis 3.6. Global Blood Grouping Reagents  Market – Regulations 3.6.1. U.S. 3.6.2. Europe 3.7. Global Blood Grouping Reagents  Market –Trends
  1. Global Blood Grouping Reagents Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2012 – 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Oppurtunity Analysis
  1. Global Blood Grouping Reagents Market, By Product, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Consumables 5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3. Market Opportunity Analysis 5.2. Instruments 5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3. Market Opportunity Analysis
  1. Global Blood Grouping Reagents Market Forecast, By Technique, 2013 - 2017 and Forecast, 2018 – 2024
6.1. PCR-based and Microarray Technique 6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Assay-Based Techniques 6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Massively Parallel Sequencing Techniques 6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis 6.4. Other Techniques 6.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.4.3. Market Opportunity Analysis
  1. Global Blood Grouping Reagents Market Forecast, By Test Type, 2013 - 2017 and Forecast, 2018 – 2024
7.1. Antibody Screening 7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. HLA Typing 7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Cross-Matching Tests 7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 7.4. ABO Blood Tests 7.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.4.3. Market Opportunity Analysis 7.5. Antigen Typing 7.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.5.3. Market Opportunity Analysis
  1. Global Blood Grouping Reagents Market Forecast, By End - Use, 2013 - 2017 and Forecast, 2018 – 2024
8.1. Hospitals 8.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Blood Banks 8.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. Clinical Laboratories 8.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis
  1. Global Blood Grouping Reagents Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. North America 9.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.1.3. Market Opportunity Analysis 9.2. Europe 9.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.2.3. Market Opportunity Analysis 9.3. Asia-Pacific 9.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.3.3. Market Opportunity Analysis 9.4. Latin America 9.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.4.3. Market Opportunity Analysis 9.5. Middle East and Africa 9.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.5.3. Market Opportunity Analysis 9.6. Global Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Region, 2018 – 2024
  1. North America Blood Grouping Reagents Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Product Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.1. Consumables 10.1.2. Instruments 10.2. Technique Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.2.1. PCR-based and Microarray Technique 10.2.2. Assay-Based Techniques 10.2.3. Massively Parallel Sequencing Techniques 10.2.4. Other Techniques 10.3. Test Type Analysis, 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.3.1. Antibody Screening 10.3.2. HLA Typing 10.3.3. Cross-Matching Tests 10.3.4. ABO Blood Tests 10.3.5. Antigen Typing 10.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.4.1. Hospitals 10.4.2. Blood Banks 10.4.3. Clinical Laboratories 10.5. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.5.1. U.S. 10.5.2. Canada 10.6. North America Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 – 2024 10.7. North America Blood Grouping Reagents  Market Dynamics – Trends
  1. Europe Blood Grouping Reagents Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Product Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.1.1. Consumables 11.1.2. Instruments 11.2. Technique Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.2.1. PCR-based and Microarray Technique 11.2.2. Assay-Based Techniques 11.2.3. Massively Parallel Sequencing Techniques 11.2.4. Other Techniques 11.3. Test Type Analysis, 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.3.1. Antibody Screening 11.3.2. HLA Typing 11.3.3. Cross-Matching Tests 11.3.4. ABO Blood Tests 11.3.5. Antigen Typing 11.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.4.1. Hospitals 11.4.2. Blood Banks 11.4.3. Clinical Laboratories 11.5. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.5.1. Germany 11.5.2. UK 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Russia 11.5.7. Poland 11.5.8. Rest of Europe 11.6. Europe Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 – 2024 11.7. Europe Blood Grouping Reagents  Market Dynamics – Trends
  1. Asia-Pacific Blood Grouping Reagents Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Product Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.1. Consumables 12.1.2. Instruments 12.2. Technique Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.2.1. PCR-based and Microarray Technique 12.2.2. Assay-Based Techniques 12.2.3. Massively Parallel Sequencing Techniques 12.2.4. Other Techniques 12.3. Test Type Analysis, 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.3.1. Antibody Screening 12.3.2. HLA Typing 12.3.3. Cross-Matching Tests 12.3.4. ABO Blood Tests 12.3.5. Antigen Typing 12.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.4.1. Hospitals 12.4.2. Blood Banks 12.4.3. Clinical Laboratories 12.5. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 12.5.1. Japan 12.5.2. China 12.5.3. India 12.5.4. ASEAN 12.5.5. Australia & New Zealand 12.5.6. Rest of Asia-Pacific 12.6. Asia-Pacific Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 – 2024 12.7. Asia-Pacific Blood Grouping Reagents  Market Dynamics – Trends
  1. Latin America Blood Grouping Reagents Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
13.1. Product Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.1.1. Consumables 13.1.2. Instruments 13.2. Technique Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.2.1. PCR-based and Microarray Technique 13.2.2. Assay-Based Techniques 13.2.3. Massively Parallel Sequencing Techniques 13.2.4. Other Techniques 13.3. Test Type Analysis, 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.3.1. Antibody Screening 13.3.2. HLA Typing 13.3.3. Cross-Matching Tests 13.3.4. ABO Blood Tests 13.3.5. Antigen Typing 13.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.4.1. Hospitals 13.4.2. Blood Banks 13.4.3. Clinical Laboratories 13.5. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Argentina 13.5.4. Venezuela 13.5.5. Rest of Latin America 13.6. Latin America Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 – 2024 13.7. Latin America Blood Grouping Reagents  Market Dynamics – Trends
  1. Middle East and Africa Blood Grouping Reagents Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
14.1. Product Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 14.1.1. Consumables 14.1.2. Instruments 14.2. Technique Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.2.1. PCR-based and Microarray Technique 14.2.2. Assay-Based Techniques 14.2.3. Massively Parallel Sequencing Techniques 14.2.4. Other Techniques 14.3. Test Type Analysis, 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 14.3.1. Antibody Screening 14.3.2. HLA Typing 14.3.3. Cross-Matching Tests 14.3.4. ABO Blood Tests 14.3.5. Antigen Typing 14.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 14.4.1. Hospitals 14.4.2. Blood Banks 14.4.3. Clinical Laboratories 14.5. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 14.5.1. Gulf Cooperation Council (GCC) Countries 14.5.2. Israel 14.5.3. South Africa 14.5.4. Rest of MEA 14.6. MEA Blood Grouping Reagents  Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 – 2024 14.7. MEA Blood Grouping Reagents  Market Dynamics – Trends
  1. Competition Landscape
15.1. Strategic Dashboard of Top Market Players 15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) 15.2.1. Grifols, S.A. (Spain) 15.2.2. Bio-Rad Laboratories, Inc. (U.S.) 15.2.3. Immucor, Inc. (U.S.) 15.2.4. Quotient, Ltd. (U.S.) 15.2.5. Novacyt Group (France) 15.2.6. Ortho Clinical Diagnostics, Inc. (U.S.) 15.2.7. BAG Healthcare GmbH (Germany) 15.2.8. Day medical SA (Switzerland) 15.2.9. Rapid Labs (U.K.) 15.2.10. AXO Science (France) 15.2.11. DIAGAST (France)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Grifols, S.A. (Spain)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Immucor, Inc. (U.S.)
  • Quotient, Ltd. (U.S.)
  • Novacyt Group (France)
  • Ortho Clinical Diagnostics, Inc. (U.S.)
  • BAG Healthcare GmbH (Germany)
  • Day medical SA (Switzerland)
  • Rapid Labs (U.K.)
  • AXO Science (France)
  • DIAGAST (France)